You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PRS

Showing 1 - 25 of 1,211
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Retrospective Assessment of OviTex PRS (OviTex)

Recruiting
  • Reconstructive Surgical Procedures
  • OviTex® PRS
  • Atlanta, Georgia
    Y Plastic Surgery
Feb 20, 2023

Healthy Trial (Placebo, PRS-220)

Not yet recruiting
  • Healthy
  • (no location specified)
Jul 21, 2022

MDR-TB Trial in Shanghai (PRS Regimen V, MDR-TB Treatment Regimen(WHO))

Recruiting
  • MDR-TB
  • PRS Regimen V
  • MDR-TB Treatment Regimen(WHO)
  • Shanghai, China
    Shanghai Pulmonary Hospital
Aug 4, 2022

Surgery, Cancer Trial in Philadelphia (Intensified post-discharge surveillance, Standard post-discharge surveillance)

Not yet recruiting
  • Surgery
  • Cancer
  • Intensified post-discharge surveillance
  • Standard post-discharge surveillance
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center - Philadelphia
Jul 12, 2022

Solid Tumor Trial in Worldwide (PRS-344/S095012)

Recruiting
  • Solid Tumor
  • Huntersville, North Carolina
  • +10 more
Jun 29, 2022

The SurgiMend PRS Retrospective Study

Recruiting
  • Reconstructive Surgical Procedures
  • SurgiMend PRS
  • Orpington, London, United Kingdom
  • +5 more
Feb 17, 2022

Cardiovascular Diseases Trial in Roma (PRS, Digital app and wearable device)

Not yet recruiting
  • Cardiovascular Diseases
  • PRS
  • Digital app and wearable device
  • Roma, Italia, Italy
    Dipartimento Universitario di Scienze della Vita e Sanità Pubbli
May 29, 2023

Clinical Implementation ofPolygenic Risk Score for Breast Cancer

Completed
  • Breast Cancer Risk
    • Burbank, California
    • +2 more
    Mar 4, 2022

    HER2-positive Gastric Cancer Trial in United States (Cinrebafusp alfa (PRS-343) in combination with ramucirumab and paclitaxel,

    Recruiting
    • HER2-positive Gastric Cancer
    • Cinrebafusp alfa (PRS-343) in combination with ramucirumab and paclitaxel
    • Cinrebafusp alfa (PRS-343) in combination with tucatinib
    • Santa Barbara, California
    • +3 more
    Jan 14, 2022

    HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive Bladder Cancer Trial in United States (PRS-343)

    Completed
    • HER2-positive Breast Cancer
    • +3 more
    • Tucson, Arizona
    • +9 more
    Jan 18, 2022

    Genetic Predisposition to Disease Trial in Paris, Cologne (BRIDGES gene panel testing, Breast cancer risk polygenic risk score

    Completed
    • Genetic Predisposition to Disease
    • BRIDGES gene panel testing
    • +2 more
    • Paris, France
    • +1 more
    Jan 19, 2023

    Asthma Trial in Australia (PRS-060, Placebo)

    Completed
    • Asthma
    • Herston, Queensland, Australia
    • +3 more
    Dec 22, 2020

    Healthy Subjects Trial in Melbourne (PRS-060, Placebo)

    Completed
    • Healthy Subjects
    • Melbourne, Victoria, Australia
      Nucleus Network Limited
    Nov 13, 2020

    HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive Bladder Cancer Trial in United States (PRS-343 in

    Unknown status
    • HER2-positive Breast Cancer
    • +3 more
    • PRS-343 in Combination with Atezolizumab
    • Los Angeles, California
    • +7 more
    Jan 29, 2021

    Pulmonary Tuberculosis TB in Sputum: (+) Microscopy Trial in Shanghai (Group A (the standard 2HRZE/4HR regimen), Group B (New

    Completed
    • Pulmonary Tuberculosis TB in Sputum: (+) Microscopy
    • Group A (the standard 2HRZE/4HR regimen）
    • Group B (New short course PRS regimen, 4EZ(high dose)PtoCfz)
    • Shanghai, China
    • +3 more
    Nov 5, 2020

    Coronary Artery Disease, Atrial Fibrillation, Type 2 Diabetes Trial in Boston (Polygenic risk score (PRS))

    Recruiting
    • Coronary Artery Disease
    • +5 more
    • Polygenic risk score (PRS)
    • Boston, Massachusetts
      VA Boston Healthcare System
    Sep 29, 2022

    Breast Cancer Trial in Rochester, Winnipeg (Polygenic Risk Score)

    Completed
    • Breast Cancer
    • Polygenic Risk Score
    • Rochester, Minnesota
    • +1 more
    Dec 28, 2020

    Vulvar and Vaginal Atrophy Trial in United States (Estrace® Cream, Estradiol Vaginal Cream, Vehicle Cream)

    Completed
    • Vulvar and Vaginal Atrophy
    • Estrace® Cream
    • +2 more
    • Sacramento, California
    • +26 more
    Apr 22, 2022

    Anemia of Chronic Kidney Disease Trial in Czechia, Germany (PRS-080#022-DP, PRS-080-Placebo#001)

    Completed
    • Anemia of Chronic Kidney Disease
    • PRS-080#022-DP
    • PRS-080-Placebo#001
    • Brno, Czechia
    • +5 more
    Oct 17, 2019

    Reperfusion Syndrome and Vasoplegic Syndrome in Liver Transplant

    Active, not recruiting
    • Postperfusion Syndrome
    • Barcelona, Spain
      Vall d´Hebron Research Institute VHIR
    Dec 12, 2022

    Cardiovascular Diseases, Primary Prevention Trial in Tallinn, Tartu (CVD risk estimation incorporating the PRS and guideline

    Unknown status
    • Cardiovascular Diseases
    • Primary Prevention
    • CVD risk estimation incorporating the PRS and guideline based preventive interventions.
    • Standard GP care
    • Tallinn, Estonia
    • +1 more
    Feb 27, 2020

    Genomic and Dietary Aspects in Gastric Cancer Risk

    Not yet recruiting
    • Gastric Cancer
      • Roma, Italia, Italy
        Dipartimento Universitario di Scienze della Vita e Sanità Pubbli
      Jun 28, 2023

      Prospective Electronic Polygenic Risk Study

      Not yet recruiting
      • Coronary Artery Disease
        • (no location specified)
        Nov 3, 2022

        Breast Cancer Prior to Decisions on Preventive Therapy Uptake,

        Enrolling by invitation
        • Breast Cancer
        • Polygenic Risk Score
        • Scottsdale, Arizona
        • +4 more
        Apr 5, 2022

        Coronary Artery Disease, Glaucoma Trial (Genetic risk assessment)

        Not yet recruiting
        • Coronary Artery Disease
        • Glaucoma
        • Genetic risk assessment
        • (no location specified)
        Dec 13, 2021